Translational Research Center in Lung Cancer Disparities (TRACER) Project 2 (TRACER)

May 29, 2026 updated by: Virginia Commonwealth University

Biological Pathways in Stress Reactivity and Nicotine Addiction Among African American and White Smokers

The purpose of this study is to examine racial differences in smoking behaviors and stress responses between African American and white male smokers.

Study Overview

Detailed Description

Cigarette smoking is a leading cause of morbidity and mortality from lung cancer among adults in the US. Stress relief and smoking cessation is the best preventive strategy for reducing lung cancer risk and addressing racial disparities in outcomes. Despite this, racial differences are found among those that make quit attempts. Stress has been found to be related to smoking initiation, maintenance, and relapse. Yet, differences in stress responses have not been examined between African American and white smokers. Therefore, this study will examine racial differences in stress responses and smoking behaviors between African American and white male smokers

Study Type

Observational

Enrollment (Actual)

95

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90089
        • University of Southern California
    • South Carolina
      • Charleston, South Carolina, United States, 29425
        • Medical University of South Carolina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

African American and white male daily smokers who are between the ages of 18-75 and who smoke at least 5 to 10 cigarettes per day.

Description

Inclusion Criteria:

  • African American and white males
  • Between the ages of 18-75 years old
  • Smoke at least 5 to 10 cigarettes per day

Exclusion Criteria:

  • Smokers who have a serious cognitive disorder
  • Have a personal history of lung cancer
  • Personal history of usage of illicit drug and alcohol abuse
  • Enrollment in a smoking cessation treatment program during the past 6 months
  • Current use of a nicotine replacement therapy
  • Have any positive responses on the Mini International Neuropsychiatric Interview (MINI) screener

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Examining racial differences in acute stress responses
Time Frame: Within 1 month following baseline
Examine racial differences in acute stress responses using a validated psychological stress challenge called the Trier Social Stress Test (TSST)
Within 1 month following baseline
Examining changes in daily cortisol patterns according to race
Time Frame: Baseline, 4- and 8 weeks post Trier Social Stress Test laboratory visit
Examine racial differences in daily diurnal cortisol slopes to evaluate hypothalamic-pituitary-adrenal-axis dysregulation and acute stress
Baseline, 4- and 8 weeks post Trier Social Stress Test laboratory visit
Examine changes in stress responses and smoking behaviors as it relates to social determinant factors
Time Frame: Baseline, 4- and 8-weeks post Trier Social Stress Test laboratory visit
Patients will be administered a survey using validated measures to examine socioeconomic, structural, and psychosocial stressors that impact daily stress and smoking behaviors
Baseline, 4- and 8-weeks post Trier Social Stress Test laboratory visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vanessa Sheppard, PhD, Virginia Commonwealth University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 31, 2024

Primary Completion (Actual)

August 31, 2025

Study Completion (Actual)

August 31, 2025

Study Registration Dates

First Submitted

May 5, 2022

First Submitted That Met QC Criteria

August 3, 2022

First Posted (Actual)

August 5, 2022

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

May 29, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • MCC-21-18891
  • 00116801 (Other Identifier: Medical University of South Carolina)
  • HM20022956 (Other Identifier: Virginia Commonwealth University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking

Subscribe